[Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
Robertson
B
B
Sangstad
O D
OD
D001688:Biological Products; D004338:Drug Combinations; D005233:Fatty Alcohols / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010743:Phospholipids; D010767:Phosphorylcholine; D011092:Polyethylene Glycols / Q000009:adverse effects / Q000627:therapeutic use*; D011663:Pulmonary Surfactants / Q000009:adverse effects / Q000627:therapeutic use*; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy*
D001688:Biological Products; D004338:Drug Combinations; D005233:Fatty Alcohols; D010743:Phospholipids; D011663:Pulmonary Surfactants; D010767:Phosphorylcholine; D011092:Polyethylene Glycols; C047049:dipalmitoylphosphatidylcholine, hexadecanol, tyloxapol drug combination; C068291:poractant alfa
Naturlig eller syntetisk surfaktant i behandling av neonatalt åndenødssyndrom.